About
Affinity Bio Partners (ABP)
Founded in November 2014, in a transition from Christina DiArcangelo's previous company Armonia Clinical Research (first formed in 2009), ABP represents the world’s leading cutting-edge Clinical Research Organization (CRO). Affinity Bio Partners LLC endeavors to provide integral enterprise-wide solutions that facilitate the development of drugs, biologics, natraceuticals and medical devices.
ABP provides services such as, but not limited to:
-
Clinical Research Operations and Product Portfolio Development
-
Proven track record for subject recruitment and a true understanding of therapeutic areas through the partnership with Affinity Patient Advocacy
-
Enterprise-wide Strategic Mitigation Planning Solutions
-
Enterprise-wide Governance Solutions
-
Asset Procurement and Staffing Solutions
-
Advance clinical outsourcing to improve the quality, efficiency and safety of clinical research.
-
Conducting clinical trials in domestic and international settings while ensuring the safety of research participants.
-
Strengthen public understanding and confidence in clinical research, highlighting CRO expertise in all aspects of the clinical research services enterprise.
-
Global Groundbreaking Medical Cannabis and Cannabinoid Clinical Research activities
Our Mission
Affinity Bio Partners (ABP) and its affiliates ensure that on a global basis that clinical research is performed safely, ethically, with high-quality so that subjects can benefit from the development of new and novel treatments and therapies. Our partners will find that ABP is dedicated to helping their clients bring efficiency, innovation and value to the clinical research process while staying on budget and pushing timelines ahead as aggressively as possible.
Christina DiArcangelo
Founder & Chief Executive Officer
A Vision Driven by Experience, Advocacy, and Innovation
Christina DiArcangelo is a globally recognized leader in clinical research, patient advocacy, and healthcare innovation, with a career dedicated to improving outcomes for patients and advancing the future of medicine.
As the Founder and CEO of Affinity Bio Partners, Christina brings a unique, multidisciplinary perspective that bridges science, strategy, and real-world patient impact.
Her work is driven by a singular mission:
To modernize clinical research while ensuring patient safety, access, and integrity remain at the forefront.
Leadership in Clinical Research and Cannabinoid Innovation
Since 2016, Christina has been at the forefront of clinical research in emerging therapeutic areas, including cannabinoids. Her contributions have supported the advancement of research frameworks and informed broader conversations around safe, evidence-based integration of cannabinoid therapies.
Her work has played a role in helping shape how clinical research and patient advocacy intersect—particularly in areas where innovation is moving faster than regulation.
Patient Advocacy
at the Core
Christina is the Founder of Affinity Patient Advocacy, a nonprofit organization dedicated to supporting patients navigating complex healthcare challenges, including access to treatment, education, and safety.
Her advocacy work is deeply personal. Following her own family’s experience with elder abuse and financial exploitation, she became a leading voice in raising awareness around elder abuse, mental health, and systemic gaps in protection.
She is the author of Rescuing Mom, a powerful and educational account that helps individuals understand elder abuse, recognize warning signs, and take action.
Advancing Healthcare Through Technology
In addition to her work in clinical research, Christina is actively involved in developing technology-driven healthcare solutions, including precision tele-monitoring platforms that integrate AI, wearable technology, and real-time patient data.
Her focus is on:
-
Improving patient outcomes
-
Enabling early intervention
-
Enhancing data-driven decision-making in clinical and real-world settings
This forward-thinking approach positions Affinity Bio Partners at the intersection of clinical research and healthcare innovation.
Public Figure, Speaker, & Thought Leader
Christina is also the founder of the empowerment platform “I Am Christina DiArcangelo,” where she shares insights on resilience, leadership, advocacy, and navigating life’s challenges.
She hosts two podcast series:
-
I Am Christina DiArcangelo
-
Humanitarian Horizons – Christina DiArcangelo Unveiled
Through these platforms, she engages global audiences on topics including:
-
Clinical research innovation
-
Patient advocacy
-
Mental health
-
Domestic violence awareness
-
Elder abuse prevention
Her work has been featured in leading publications, including:
Forbes | ELLE | Vogue | Cosmopolitan | Entrepreneur | Billboard | MSN | Benzinga
A Different Kind of CRO Leader
Christina’s leadership philosophy is grounded in:
✔ Integrity over shortcuts
✔ Patient-first decision making
✔ Innovation with accountability
✔ Strategic execution with measurable results
Under her leadership, Affinity Bio Partners is redefining what it means to be a clinical research partner—combining scientific rigor, operational excellence, and human-centered impact.
Looking Ahead
Christina continues to lead Affinity Bio Partners with a focus on:
-
Expanding clinical research capabilities
-
Advancing emerging therapeutic areas
-
Integrating technology into clinical development
-
Advocating for stronger patient protections and regulatory clarity
Her vision is clear:
To create a more transparent, efficient, and patient-centered future for clinical research.